About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lymphoma Clinical Trials | 6,585 Studies Recruiting

Clinical TrialsLymphoma

Lymphoma Clinical Trials

Browse 6,585 clinical trials for lymphoma. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1441-1460 of 6,585 trials

CompletedMelphalan, Yttrium Y 90 Ibritumomab Tiuxetan, and Rituximab Followed by Autologous Stem Cell Transplant in Treating Older Patients With Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous TreatmentRATIONALE: Giving chemotherapy drugs, such as melphalan, before an autologous stem cell transplant helps stop the growth of cancer cells, either by killing the cells or by…NCT00392691·Aarau and 9 others RecruitingAZD0486 as Monotherapy in B-cell Acute Lymphoblastic LeukaemiaThis is a Phase 1/2, global multicentre, open-label, single-arm, dose escalation and dose optimization study of surovatamig (AZD0486) to evaluate the safety, tolerability, and…NCT06137118·Birmingham, Alabama and 81 others

Related Searches

hodgkintrials non-hodgkintrials

Data from ClinicalTrials.govTerms

RecruitingOne Trial to Evaluate the Safety, Tolerability and Efficacy of JCXH-213 in Patients With r/r B-NHLEvaluate the Safety and Efficacy of JCXH-213 in Patients with Relapsed/Refractory B-cell non-Hodgkin LymphomaNCT06618313·Beijing

Active not recruitingOccurrence of Acute Kidney Injury After CAR-T Cells Treatments in B-cell Lymphoma.The investigators want to describe the incidence of AKI after CAR-T cells therapy in B-cell lymphoma. With the aim of highlight risk factors in AKI occurrence.NCT07101913·Pierre-Bénite, France

CompletedDNA Analysis in Influencing Response to Rituximab in Samples From Patients With Follicular Lymphoma Treated on ECOG-E4402RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to…NCT01406782

CompletedStudy of the Safety and Tolerability of Oral Capsule Form of PCI-24781 in Advanced Cancer PatientsTo determine the highest dose of study drug that can be taken without causing serious side effects in patients with advanced cancer.NCT00562224·Greenbrae, California and 3 others

CompletedA Study of Duvelisib in Participants With Refractory Indolent Non-Hodgkin LymphomaThis was a Phase 2 clinical trial to evaluate the safety and efficacy of duvelisib as a monotherapy in participants with indolent non-Hodgkin lymphoma (iNHL) (follicular lymphoma…NCT01882803·Los Angeles, California and 68 others

CompletedPositron Emission Tomography (PET)-Scan in the Evaluation of High Tumor Burden Follicular LymphomaThe purpose of the study is to assess in a prospective series of patients with high tumor burden follicular lymphoma treated with R-CHOP, the predictive value of \[18F\]-FDG PET…NCT00915096·Besançon and 21 others

CompletedR-CHOP Versus R-mini-CEOP in Elderly Patients(>65)With DLBCLThe study has the purpose to compare R-CHOP versus R-mini-CEOP in elderly patients (\>65 years) with Diffuse Large B Cell Lymphoma (DLBCL).NCT01148446·Brescia, Brescia and 10 others

RecruitingImmune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin LymphomaThis phase I trial evaluates the side effects and usefulness of axicabtagene clioleucel (a CAR-T therapy) and find out what effect, if any, it has on treating patients with…NCT05077527·Duarte, California and 6 others

TerminatedA Study of CG-806 in Patients With Relapsed or Refractory CLL/SLL or Non-Hodgkin's LymphomasThis study is being done to evaluate the safety, tolerability and effectiveness of Oral CG-806 for the treatment of patients with chronic lymphocytic leukemia (CLL), small…NCT03893682·Los Angeles, California and 29 others

UnknownZevalin With Non Myeloablative Allogeneic Stem Cell Transplantation in Patients With Non Hodgkin LymphomaThe purpose of this study is to investigate the ability to combine a radioactive medication directly targeted against lymphoma cells with the immune effects of an allogeneic blood…NCT00807196·Montreal, Quebec

RecruitingCombination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/LeukemiaThis phase II trial studies the side effects and how well combination chemotherapy works in treating patients with acute lymphoblastic leukemia, lymphoblastic lymphoma, Burkitt…NCT03136146·Houston, Texas

UnknownStudy of ASC-101 in Patients With Hematologic Malignancies Who Receive Dual-cord Umbilical Cord Blood TransplantationThe goal of this clinical research study is to learn if it is safe and feasible to transplant patients with one of two units of cord blood that has been changed in the laboratory…NCT01983761·La Jolla, California and 3 others

CompletedRituximab Therapy in Follicular Lymphoma in Combination With Chemotherapy - REFLECT 1The primary objective is to evaluate the safety profile and tolerability of rituximab in combination with different chemotherapy regimens.NCT02461290·Belgrade and 5 others

WithdrawnStudy of the Trifunctional Antibody FBTA05 and Donor Lymphocyte Infusion in B-cell Lymphoma After Allogeneic Stem Cell TransplantationThis study is an investigator driven, open-label, non-randomized, uncontrolled, dose escalating Phase I/II study evaluating the safety and preliminary efficacy of the…NCT01138579·Munich, Bavaria

UnknownCD19 CAR-T Cells for Patients With Relapse and Refractory CD19+ B-ALL.This is a single center, single arm, open-lable phase 1 study to determine the safety and efficacy of CD19-CAR-T cells in patients with relapsed or refractory acute B-cell…NCT03671460·Langfang, Hebei

Active not recruitingStudy of Pembrolizumab (MK-3475) in Combination With RomidepsinThis phase I/II trial studies the side effects of pembrolizumab and romidepsin and to see how well they work in treating participants with peripheral T-cell lymphoma that has come…NCT03278782·Houston, Texas

TerminatedStudy of VAY736 as Single Agent and in Combination With Select Antineoplastic Agents in Patients With Non-Hodgkin LymphomaThe purpose of this study is to assess the safety, tolerability, pharmacokinetics (PK), immunogenicity and preliminary efficacy of VAY736 alone or in combination with other…NCT04903197·Melbourne, Victoria and 9 others

CompletedPK-directed Dose Adjustment of IV Busulfan Conditioning Regimen for Autologous Stem Cell Transplant in Lymphoma PatientsThis is a study for the outcome and safety of individualized busulfan dosing with cyclophosphamide and etoposide for patients preparing for a stem cell transplant to treat…NCT00948090·Birmingham, Alabama and 41 others

PreviousPage 73 of 330Next